Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection

COVID-19 is one of the most severe global health crises that humanity has ever faced. Researchers have restlessly focused on developing solutions for monitoring and tracing the viral culprit, SARS-CoV-2, as vital steps to break the chain of infection. Even though biomedical engineering (BME) is considered a rising field of medical sciences, it has demonstrated its pivotal role in nurturing the maturation of COVID-19 diagnostic technologies. Within a very short period of time, BME research applied to COVID-19 diagnosis has advanced with ever-increasing knowledge and

show abstract

Recent findings and applications of biomedical engineering for COVID-19 diagnosis: a critical review

Bui

Phung

Thi

et al. 2021

Bioengineered

View full text Add to dashboard Cite

show abstract

Comparison of the Otolaryngological Symptoms of Laboratory-confirmed and Clinically Diagnosed COVID-19 Patients

Dizdar¹

2022

Sisli Etfal

View full text Add to dashboard Cite

Objectives Our aim is to determine prevalence, severity, duration of otorhinolaryngologic symptoms related to coronavirus disease 2019 (COVID-19), and correlation between the test results obtained by oronasopharyngeal swab and the symptoms of these regions by evaluating differences in ear, nose, and throat (ENT) symptoms between laboratory-confirmed COVID-19 patients and clinically and computed tomography (CT)-diagnosed COVID-19 patients. Methods The study enrolled patients with a positive polymerase chain reaction (PCR) test diagnosed with COVID-19 that grouped as PCR (+), and those with repeated negative PCR tests but COVID-19 Reporting and Data System (CO-RADS) chest CT findings with high (CO-RADS 5) or very high (CO-RADS 6) similarity to COVID-19 that grouped as PCR(–)/CT(+). Demographic features, general symptoms, and otorhinolaryngological symptoms and severity of disease were evaluated and compared. Results The most common ENT symptoms in the PCR(+) group were loss of taste (n=77), loss of smell, and sore throat with respective frequencies of 34.5%, 31.8%, 26.0%, and in PCR(−) CT (+) group loss of taste, loss of smell, and sore throat with respective frequencies 24.6%, 21.1%, and 18.4%. ENT symptom rates were found higher in PCR (+) group (65.0%) according to PCR(–)/CT(+) group (49.1%) with statistically significant difference (p=0.008). Loss of smell rates were found higher in PCR (+) group according to PCR(–)/CT(+) group with statistically significant difference (p=0.037). Conclusion Loss of smell and taste were most common ENT symptoms in laboratory-confirmed COVID-19 cases. The presence of COVID-19 should definitely be considered in patients presenting with sudden loss of smell or taste. In addition, loss of smell and otolaryngologic symptoms were more common in laboratory-confirmed COVID-19 according to clinically and computed tomograpy diagnosed COVID-19 cases. There can be a correlation between positive sample region and symptom region. Location of symptoms must be considered for decision of sampling location.

show abstract

Obsidade Como Fator De Risco Em Pessoas Infectadas Pelo Covid-19

Almeida¹,

Rolim²

2022

View full text Add to dashboard Cite

Objetivo: avaliar as correlações da obesidade como fator de risco para as complicações em pessoas infectadas com COVID-19. Métodos: O presente estudo trata-se de uma revisão sistemática da literatura, com caráter qualitativo. Como ferramenta de pesquisa as bases de dados a serem selecionadas são a Medical Publisher (PUBMED) e a Science Direct, com o objetivo de selecionar artigos que relacionem a obesidade como fator de risco para a infecção pelo COVID-19. O presente estudo irá selecionar artigos relacionados com a obesidade como fator de risco para o desenvolvimento de formas graves pela infecção do SARS-CoV-2, compreender esse mecanismo e quais a comorbidades mais prevalente. A população-alvo são pacientes analisados em estudos observacionais que contraíram a infecção pelo COVID-19 e que apresentassem outras comorbidades. Resultados: pacientes com condições crônicas pré-existentes, como obesidade, diabetes, hipertensão, doenças cardiovasculares doenças renais, doenças pulmonares, tabagismo, elevação de marcadores pró-inflamatórios apresentam versões mais graves da doença causada pelo novo Coronavírus, a COVID-19. Conclusão: Idade avançada, sexo masculino, comorbidades crônicas importantes, tais como doenças cardiovasculares, doença pulmonar, doença renal crônica, doença hepática, obesidade, tabagismo foram associados com maior mortalidade e pior prognóstico.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection

Cited by 3 publications

References 0 publications

Recent findings and applications of biomedical engineering for COVID-19 diagnosis: a critical review

Recent findings and applications of biomedical engineering for COVID-19 diagnosis: a critical review

Comparison of the Otolaryngological Symptoms of Laboratory-confirmed and Clinically Diagnosed COVID-19 Patients

Obsidade Como Fator De Risco Em Pessoas Infectadas Pelo Covid-19

Contact Info

Product

Resources

About